<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>5-MeO-DIPT - Complete Profile</title>
    <link rel="stylesheet" href="/Dyo-s-Dubious-Domain/style.css">
    <link rel="icon" type="image/svg+xml" href="/Dyo-s-Dubious-Domain/assets/logo.svg">
    <script>
        // Set base path for JavaScript files to use
        window.SITE_BASE_PATH = '/Dyo-s-Dubious-Domain/';
    </script>
</head>

<body class="
  
  
  
  ">
    <header class="page-header">
  <div class="container">
    <div class="page-header__content">
      <div class="logo-container">
        <a href="/Dyo-s-Dubious-Domain/" class="site-title">Dyo's Dubious Domain</a>
      </div>
      
      <nav>
        <ul role="list" class="nav-list flex-group">
          <li>
            <a href="/Dyo-s-Dubious-Domain/">Home</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/dyos-domain/">Dyo's Domain</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/about/">About</a>
          </li>
          <li>
            <a href="/Dyo-s-Dubious-Domain/profile/">My Profile</a>
          </li>
         
        </ul>
      </nav>
    </div>
    
    <!-- Search Bar - Now underneath header -->
    <div class="search-container">
      <input type="text" id="search-input" placeholder="Search substances..." class="search-input" />
      <div id="search-results" class="search-results" style="display: none;"></div>
    </div>
  </div>
</header>

    <main>
      
<div class="substance-profile-header">
  <div class="container">
    <nav class="breadcrumb">
      <a href="/dyos-domain/">Dyo's Domain</a> ‚Üí <a href="/dyos-domain/psychedelics/">Psychedelics</a> ‚Üí <span>5-MeO-DIPT</span>
    </nav>
    
    <div class="substance-hero">
      <div class="substance-info">
        <h1>ü¶ä 5-MeO-DIPT</h1>
        <h2 class="chemical-name">5-Methoxy-N,N-diisopropyltryptamine</h2>
          
        <!-- Add to Profile Button -->
        <button id="add-to-profile-btn" class="add-to-profile-btn not-in-profile" 
                data-substance="5-MeO-DIPT" 
                data-category="Psychedelics" 
                data-chemical="5-Methoxy-N,N-diisopropyltryptamine">
          + Add to My Profile
        </button>
        
        <div class="alternative-names">
          <h3>Alternative Names & Slang</h3>
          <div class="names-grid">
            <div class="name-category">
              <h4>Common Names</h4>
              <span>Foxy</span> ‚Ä¢ <span>Foxy Methoxy</span> ‚Ä¢ <span>5-MeO-DiPT</span> ‚Ä¢ <span>DiPT</span>
            </div>
            <div class="name-category">
              <h4>Street Names</h4>
              <span>Fox</span> ‚Ä¢ <span>Sexy</span> ‚Ä¢ <span>Sound Drug</span> ‚Ä¢ <span>Audio Enhancement</span>
            </div>
            <div name-category">
              <h4>Chemical Names</h4>
              <span>5-Methoxy-DiPT</span> ‚Ä¢ <span>N,N-Diisopropyl-5-MeOT</span> ‚Ä¢ <span>Methoxy-DIPT</span>
            </div>
            <div class="name-category">
              <h4>Research Codes</h4>
              <span>CAS: 4021-34-5</span> ‚Ä¢ <span>Shulgin's Foxy</span> ‚Ä¢ <span>TiHKAL #38</span>
            </div>
          </div>
        </div>
        
        <div class="substance-meta-large">
          <span class="category sexual-enhancement">Sexual Enhancement</span>
          <span class="legal-status schedule-1">Schedule I</span>
          <span class="duration medium-long">6-10 hours</span>
        </div>
      </div>
      
      <div class="substance-visual">
        <div class="substance-image">
          <img src="/assets/substances/5-meo-dipt.jpg" alt="5-MeO-DIPT crystals and molecular structure" class="substance-photo">
          <div class="image-caption">
            <p><strong>Distinctive Properties:</strong> Known for unique auditory effects and significant sexual enhancement at moderate doses</p>
          </div>
        </div>
        <div class="molecule-structure">
          <div class="structure-placeholder">
            <p>üß¨ C‚ÇÅ‚ÇáH‚ÇÇ‚ÇÜN‚ÇÇO</p>
            <p>MW: 274.40 g/mol</p>
          </div>
        </div>
      </div>
    </div>
  </div>
</div>

<div class="container">
  
  <div class="profile-grid">
    
    <div class="profile-section identification">
      <h3>üîç Physical Identification</h3>
      <div class="identification-info">
        <div class="pure-form">
          <h4>Pure 5-MeO-DIPT (freebase/fumarate)</h4>
          <ul>
            <li><strong>Appearance:</strong> White to off-white crystalline powder</li>
            <li><strong>Texture:</strong> Fine crystalline powder, sometimes slightly waxy</li>
            <li><strong>Odor:</strong> Distinct chemical smell, sometimes described as "fishy" or amine-like</li>
            <li><strong>Taste:</strong> Extremely bitter and unpleasant, lingering aftertaste</li>
            <li><strong>Solubility:</strong> Moderately soluble in water, better in alcohol</li>
          </ul>
        </div>
        
        <div class="synthesis-info">
          <h4>Synthesis & Availability</h4>
          <ul>
            <li><strong>First synthesis:</strong> Alexander Shulgin, documented in TiHKAL</li>
            <li><strong>Research chemical era:</strong> Widely available online 2000-2004</li>
            <li><strong>Current availability:</strong> Rare due to scheduling, occasional darknet presence</li>
            <li><strong>Quality concerns:</strong> Often misrepresented or adulterated when available</li>
          </ul>
        </div>
        
        <div class="adulterants-warning">
          <h4>‚ö†Ô∏è Common Adulterants & Confusion</h4>
          <p><strong>Often confused with:</strong> DiPT (no methoxy), 5-MeO-DMT (different effects entirely)</p>
          <p><strong>Street adulterants:</strong> Other tryptamines, phenethylamines, inactive fillers</p>
          <p><strong>Identification critical:</strong> Unique effects profile - test and verify before use</p>
        </div>
      </div>
    </div>
    
    <div class="profile-section dosage">
      <h3>üíä Dosage Guidelines</h3>
      <div class="dosage-chart">
        <div class="dose-range threshold">
          <span class="range-label">Threshold</span>
          <span class="dose-amount">3-6mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range light">
          <span class="range-label">Light</span>
          <span class="dose-amount">6-10mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range common">
          <span class="range-label">Common</span>
          <span class="dose-amount">10-20mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range strong">
          <span class="range-label">Strong</span>
          <span class="dose-amount">20-30mg</span>
          <div class="dose-bar"></div>
        </div>
        <div class="dose-range heavy">
          <span class="range-label">Heavy</span>
          <span class="dose-amount">30mg+</span>
          <div class="dose-bar"></div>
        </div>
      </div>
      
      <div class="dosage-details">
        <h4>Critical Dosage Information</h4>
        <ul>
          <li><strong>Sexual enhancement:</strong> 6-12mg optimal range for aphrodisiac effects</li>
          <li><strong>Psychedelic threshold:</strong> 15mg+ for visual and consciousness effects</li>
          <li><strong>Individual variation:</strong> Sensitivity varies significantly between users</li>
          <li><strong>Redosing:</strong> Not recommended due to long duration and tolerance</li>
          <li><strong>Route sensitivity:</strong> Oral most common, insufflation more intense but shorter</li>
          <li><strong>First time:</strong> 6-8mg maximum to assess individual sensitivity</li>
        </ul>
      </div>
      
      <div class="route-specific">
        <h4>Route of Administration</h4>
        <ul>
          <li><strong>Oral (most common):</strong> 6-25mg, 45-90 min onset, full duration</li>
          <li><strong>Insufflated:</strong> 3-15mg, 15-30 min onset, shorter duration, more intense</li>
          <li><strong>Rectal:</strong> 5-20mg, 20-45 min onset, reliable absorption</li>
          <li><strong>Smoked (rare):</strong> 5-15mg, immediate onset, much shorter duration</li>
        </ul>
      </div>
    </div>

    <div class="profile-section effects">
      <h3>‚ú® Effects Profile</h3>
      
      <div class="effects-timeline">
        <h4>Timeline (Oral)</h4>
        <div class="timeline-item">
          <span class="time">T+0:45-1:30</span>
          <span class="effect">Onset - body warmth, mild alertness, auditory changes</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+1:30-4:00</span>
          <span class="effect">Peak - sexual enhancement, sound distortions, mild visuals</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+4:00-8:00</span>
          <span class="effect">Plateau - sustained effects, tactile enhancement</span>
        </div>
        <div class="timeline-item">
          <span class="time">T+8:00-12:00</span>
          <span class="effect">Comedown - gradual return to baseline, potential fatigue</span>
        </div>
      </div>

      <div class="effects-categories">
        <div class="effect-category distinctive">
          <h4>üéµ Distinctive Auditory Effects</h4>
          <ul>
            <li>Sound pitch alterations (everything sounds lower/higher)</li>
            <li>Music appreciation enhancement</li>
            <li>Audio distortions and flanging effects</li>
            <li>Increased sensitivity to sound details</li>
            <li>Voice changes (own voice sounds different)</li>
            <li>Echo and reverb perception changes</li>
          </ul>
        </div>
        
        <div class="effect-category sexual">
          <h4>üíï Sexual Enhancement Effects</h4>
          <ul>
            <li>Dramatically increased libido and sexual interest</li>
            <li>Enhanced tactile sensitivity and pleasure</li>
            <li>Intensified orgasms and sexual sensations</li>
            <li>Increased emotional intimacy and connection</li>
            <li>Extended sexual endurance and arousal</li>
            <li>Enhanced appreciation of physical touch</li>
          </ul>
        </div>
        
        <div class="effect-category psychedelic">
          <h4>üåÄ Psychedelic Effects (Higher Doses)</h4>
          <ul>
            <li>Mild to moderate visual distortions</li>
            <li>Color enhancement and saturation</li>
            <li>Pattern recognition and geometric visuals</li>
            <li>Altered perception of time</li>
            <li>Introspective thoughts and insights</li>
            <li>Mild ego softening (not full dissolution)</li>
          </ul>
        </div>
        
        <div class="effect-category negative">
          <h4>‚ùå Negative Effects</h4>
          <ul>
            <li>Nausea and stomach discomfort (especially onset)</li>
            <li>Increased body temperature and sweating</li>
            <li>Jaw tension and muscle tightness</li>
            <li>Insomnia and difficulty sleeping</li>
            <li>Anxiety or restlessness (higher doses)</li>
            <li>Dehydration and increased thirst</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section pharmacology">
      <h3>üß† Pharmacology & Neuroscience</h3>
      <div class="pharma-details">
        <h4>Primary Mechanism of Action</h4>
        <p>5-MeO-DIPT acts primarily as a serotonin receptor agonist with particular affinity for 5-HT1A and 5-HT2A receptors. The diisopropyl substitution creates unique pharmacokinetic properties compared to other tryptamines, resulting in its distinctive sexual enhancement and auditory effects profile. Unlike many psychedelics, it shows moderate selectivity for different receptor subtypes.</p>
        
        <h4>Detailed Receptor Pharmacology</h4>
        <div class="receptor-table">
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT1A receptor</strong></span>
            <span class="affinity">High affinity agonist</span>
            <span class="function">Sexual enhancement, anxiolytic effects, mood elevation</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT2A receptor</strong></span>
            <span class="affinity">Moderate affinity agonist</span>
            <span class="function">Psychedelic effects, visual distortions (higher doses)</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT2C receptor</strong></span>
            <span class="affinity">Moderate affinity</span>
            <span class="function">Appetite suppression, mood effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>5-HT7 receptor</strong></span>
            <span class="affinity">Notable affinity</span>
            <span class="function">May contribute to unique auditory effects</span>
          </div>
          <div class="receptor-row">
            <span class="receptor-name"><strong>Alpha-adrenergic</strong></span>
            <span class="affinity">Weak activity</span>
            <span class="function">Mild cardiovascular and autonomic effects</span>
          </div>
        </div>

        <h4>Unique Pharmacological Properties</h4>
        <ul>
          <li><strong>Diisopropyl structure:</strong> Bulky N-substituents create unique receptor selectivity and metabolism</li>
          <li><strong>Sexual enhancement mechanism:</strong> 5-HT1A activation increases nitric oxide, enhances genital blood flow</li>
          <li><strong>Auditory processing:</strong> Affects auditory cortex processing, potentially through 5-HT7 receptors</li>
          <li><strong>Moderate psychedelic potency:</strong> Less intense consciousness alteration than classical psychedelics</li>
          <li><strong>Long duration:</strong> Slower metabolism due to steric hindrance from diisopropyl groups</li>
        </ul>

        <h4>Metabolism & Pharmacokinetics</h4>
        <div class="metabolism-details">
          <p><strong>Primary Pathway:</strong> N-dealkylation and O-demethylation by liver enzymes</p>
          <p><strong>Half-life:</strong> 6-10 hours (longer than most tryptamines)</p>
          <p><strong>Bioavailability:</strong> ~60-80% oral administration</p>
          <p><strong>Peak plasma:</strong> 1-3 hours after oral dose</p>
          <p><strong>Duration factors:</strong> Diisopropyl groups slow metabolism, extend effects</p>
          <p><strong>Elimination:</strong> Primarily renal, with metabolites detectable for 24-48 hours</p>
        </div>

        <h4>Sexual Enhancement Mechanisms</h4>
        <div class="sexual-enhancement-info">
          <p><strong>5-HT1A activation:</strong> Increases nitric oxide synthase activity, enhances genital blood flow</p>
          <p><strong>Dopamine interaction:</strong> May enhance dopaminergic reward pathways related to sexual pleasure</p>
          <p><strong>Tactile sensitivity:</strong> Serotonergic enhancement of touch receptors and processing</p>
          <p><strong>Inhibition reduction:</strong> Reduces sexual inhibitions while maintaining awareness and control</p>
        </div>

        <h4>Auditory Effect Mechanisms</h4>
        <div class="auditory-effects-info">
          <p><strong>Auditory cortex modulation:</strong> Alters frequency processing and pitch perception</p>
          <p><strong>Temporal processing:</strong> Changes time perception of audio signals</p>
          <p><strong>5-HT7 involvement:</strong> May contribute to unique auditory hallucinations and distortions</p>
          <p><strong>Cross-modal enhancement:</strong> Increases connectivity between auditory and other sensory areas</p>
        </div>
      </div>
    </div>

    <div class="profile-section safety">
      <h3>‚ö†Ô∏è Safety & Harm Reduction</h3>
      
      <div class="safety-grid">
        <div class="safety-item critical">
          <h4>üö® Critical Warnings</h4>
          <ul>
            <li><strong>Long duration:</strong> 8-12 hour experience, plan accordingly</li>
            <li><strong>Sexual context risks:</strong> Impaired judgment in sexual situations</li>
            <li><strong>Cardiovascular effects:</strong> Increased heart rate and blood pressure</li>
            <li><strong>Hyperthermia risk:</strong> Body temperature elevation, especially in warm environments</li>
            <li><strong>Drug interactions:</strong> Dangerous with MAOIs and some medications</li>
          </ul>
        </div>
        
        <div class="safety-item precautions">
          <h4>üõ°Ô∏è Essential Precautions</h4>
          <ul>
            <li>Start with low doses (6-8mg) to assess sensitivity</li>
            <li>Trusted environment with reliable people</li>
            <li>Stay hydrated but avoid excessive water intake</li>
            <li>Avoid hot environments (clubs, saunas, etc.)</li>
            <li>Have reliable transportation arranged</li>
            <li>Clear sexual boundaries beforehand if applicable</li>
            <li>Avoid combining with other substances</li>
          </ul>
        </div>
      </div>

      <div class="sexual-safety">
        <h4>üíï Sexual Safety Considerations</h4>
        <div class="sexual-safety-info">
          <ul>
            <li><strong>Consent awareness:</strong> Maintain clear communication and ongoing consent</li>
            <li><strong>STI protection:</strong> Enhanced sensation doesn't reduce STI risk - use protection</li>
            <li><strong>Partner awareness:</strong> Ensure partner knows about substance use</li>
            <li><strong>Boundary setting:</strong> Establish clear boundaries before use</li>
            <li><strong>Dehydration risk:</strong> Extended sexual activity increases dehydration risk</li>
          </ul>
        </div>
      </div>

      <div class="contraindications">
        <h4>üö´ Contraindications</h4>
        <p><strong>Do not use if you have:</strong> Heart conditions, high blood pressure, seizure disorders, psychiatric conditions, are taking psychiatric medications, or have a history of hyperthermia or heat-related illness.</p>
      </div>
    </div>

    <div class="profile-section interactions">
      <h3>‚öóÔ∏è Drug Interactions</h3>
      
      <div class="interaction-levels">
        <div class="interaction dangerous">
          <h4>üî¥ Extremely Dangerous</h4>
          <ul>
            <li><strong>MAOIs:</strong> Risk of serotonin syndrome, hypertensive crisis</li>
            <li><strong>SSRIs/SNRIs:</strong> Serotonin syndrome risk, unpredictable interactions</li>
            <li><strong>Tramadol:</strong> High seizure risk and serotonin syndrome</li>
            <li><strong>Lithium:</strong> Risk of seizures and serotonin toxicity</li>
          </ul>
        </div>
        
        <div class="interaction risky">
          <h4>üü° High Risk</h4>
          <ul>
            <li><strong>Stimulants:</strong> Dangerous cardiovascular strain, hyperthermia</li>
            <li><strong>MDMA:</strong> Excessive serotonergic activity, overheating</li>
            <li><strong>Other tryptamines:</strong> Unpredictable combined effects</li>
            <li><strong>Alcohol:</strong> Impaired judgment, dehydration, nausea</li>
          </ul>
        </div>
        
        <div class="interaction caution">
          <h4>üü† Use Extreme Caution</h4>
          <ul>
            <li><strong>Cannabis:</strong> May increase anxiety or paranoia</li>
            <li><strong>2C-x compounds:</strong> Unpredictable serotonergic interactions</li>
            <li><strong>Benzodiazepines:</strong> May mask dangerous symptoms</li>
            <li><strong>Nitrous oxide:</strong> Risk of falls, oxygen deprivation</li>
          </ul>
        </div>
      </div>
    </div>

    <div class="profile-section legal">
      <h3>‚öñÔ∏è Legal Status</h3>
      <div class="legal-info">
        <div class="legal-jurisdictions">
          <div class="jurisdiction">
            <h4>üá∫üá∏ United States</h4>
            <p><strong>Schedule I</strong> - Illegal to manufacture, possess, or distribute since 2004. Emergency scheduled due to increasing recreational use.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¨üáß United Kingdom</h4>
            <p><strong>Class A</strong> - Covered under tryptamine scheduling. Up to 7 years for possession, life for supply.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá™üá∫ European Union</h4>
            <p><strong>Controlled</strong> - Most EU countries have specifically scheduled 5-MeO-DIPT due to research chemical concerns.</p>
          </div>
          <div class="jurisdiction">
            <h4>üá¶üá∫ Australia</h4>
            <p><strong>Schedule 9</strong> - Prohibited substance. Covered under tryptamine analog legislation.</p>
          </div>
        </div>
        
        <div class="scheduling-history">
          <h4>üìÖ Scheduling History</h4>
          <p>5-MeO-DIPT was emergency scheduled in the US in 2004 after becoming popular in the research chemical scene. Its unique sexual enhancement properties and availability led to widespread recreational use, prompting rapid regulatory response worldwide.</p>
        </div>
      </div>
    </div>

    <div class="profile-section history">
      <h3>üìö History & Culture</h3>
      
      <div class="history-timeline">
        <div class="history-event">
          <span class="year">1981</span>
          <p>First synthesized and documented by Alexander Shulgin</p>
        </div>
        <div class="history-event">
          <span class="year">1991</span>
          <p>Published in TiHKAL as compound #38 with detailed notes</p>
        </div>
        <div class="history-event">
          <span class="year">1999-2003</span>
          <p>Becomes popular in research chemical community as "Foxy"</p>
        </div>
        <div class="history-event">
          <span class="year">2004</span>
          <p>Emergency scheduled in US due to recreational use and overdoses</p>
        </div>
        <div class="history-event">
          <span class="year">2004-2010</span>
          <p>Worldwide scheduling follows US lead</p>
        </div>
        <div class="history-event">
          <span class="year">2010s</span>
          <p>Remains in underground scenes, periodic research interest</p>
        </div>
      </div>

      <div class="cultural-impact">
        <h4>Cultural Significance</h4>
        <p>5-MeO-DIPT occupied a unique niche in psychedelic culture as the primary "sexual psychedelic." Unlike MDMA's empathogenic love, or classical psychedelics' mystical experiences, "Foxy" was specifically sought for intimate and sexual enhancement. It became popular in couples' exploration and tantric communities, earning nicknames like "the love drug" and "Shulgin's aphrodisiac."</p>
      </div>

      <div class="research-chemical-era">
        <h4>Research Chemical Era</h4>
        <p>During the early 2000s research chemical boom, 5-MeO-DIPT was among the most popular novel psychedelics. Online vendors sold it legally as a "research chemical," and its unique effects profile attracted users seeking alternatives to scheduled substances. However, emergency room visits and overdoses led to rapid scheduling.</p>
      </div>

      <div class="shulgin-legacy">
        <h4>Shulgin's Assessment</h4>
        <p>Alexander Shulgin rated 5-MeO-DIPT highly in TiHKAL, noting its "remarkable" effects on sexuality and audio perception. He described it as having a "gentle psychedelic action" with "dramatic enhancement of tactile and sexual sensitivity." Shulgin emphasized its potential therapeutic applications in couples therapy and sexual dysfunction treatment.</p>
      </div>
    </div>

    <div class="profile-section research">
      <h3>üî¨ Current Research</h3>
      
      <div class="research-areas">
        <div class="research-item">
          <h4>Sexual Dysfunction Treatment</h4>
          <p>Limited research explores 5-MeO-DIPT's potential for treating sexual dysfunction, particularly in cases where psychological factors contribute to sexual difficulties. Its unique mechanism differs from PDE5 inhibitors.</p>
        </div>
        
        <div class="research-item">
          <h4>Couples Therapy Applications</h4>
          <p>Some therapeutic practitioners have investigated 5-MeO-DIPT's potential in couples therapy, particularly for addressing sexual intimacy issues within established relationships.</p>
        </div>
        
        <div class="research-item">
          <h4>Auditory Processing Research</h4>
          <p>The compound's unique auditory effects have attracted interest from neuroscientists studying auditory processing and cross-modal sensory interactions in the brain.</p>
        </div>
        
        <div class="research-item">
          <h4>Receptor Selectivity Studies</h4>
          <p>Pharmacological research continues to explore 5-MeO-DIPT's unique receptor profile to understand its distinctive effects compared to other tryptamines.</p>
        </div>
      </div>
    </div>

  </div>

  <div class="substance-resources">
    <h3>üìñ Additional Resources</h3>
    <div class="resources-grid">
      <div class="resource-item">
        <h4>Safety & Testing</h4>
        <ul>
          <li><a href="https://drugsdata.org/">DrugsData.org</a> - Lab testing service</li>
          <li><a href="https://dancesafe.org/">DanceSafe</a> - Reagent test kits</li>
          <li><a href="https://bunkpolice.com/">The Bunk Police</a> - Testing supplies</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Educational Resources</h4>
        <ul>
          <li><a href="https://erowid.org/">Erowid</a> - Experience reports and information</li>
          <li><a href="https://psychonautwiki.org/">PsychonautWiki</a> - Comprehensive drug information</li>
          <li><a href="https://www.shulginresearch.org/">Shulgin Research</a> - TiHKAL and scientific data</li>
        </ul>
      </div>
      
      <div class="resource-item">
        <h4>Support & Community</h4>
        <ul>
          <li><a href="https://bluelight.org/">Bluelight</a> - Harm reduction forum</li>
          <li><a href="https://reddit.com/r/researchchemicals">/r/ResearchChemicals</a> - Community discussion</li>
          <li><a href="https://psychedelicsafety.com/">Psychedelic Safety</a> - Crisis support</li>
        </ul>
      </div>
    </div>
  </div>

  <div class="disclaimer-box">
    <h3>‚ö†Ô∏è Important Disclaimer</h3>
    <p>5-MeO-DIPT is a powerful and long-lasting psychoactive substance with unique effects on sexuality and perception. Its aphrodisiac properties can impair judgment regarding sexual decisions and consent. This information is provided for educational purposes only. The substance is illegal in most jurisdictions and carries significant legal and health risks. Always prioritize safety, consent, and harm reduction practices.</p>
  </div>

</div>
    </main>
     <div class="footer-divider"></div>
<footer class="site-footer">
  
</footer>




<footer class="site-footer">
  
  </svg>
    <img src="/Dyo-s-Dubious-Domain/assets/logo.svg" alt="My Logo" class="logo">
     <p>¬© 2025 Uwaniumnya. Highly Illegal.</p>
  </footer>

  

    <!-- Search Scripts -->
    <script src="/Dyo-s-Dubious-Domain/js/lunr.min.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/search.js"></script>
    <script src="/Dyo-s-Dubious-Domain/assets/js/substance-integration.js"></script>
    
    <!-- Only load profile.js on profile page -->
    
</body>
</html>